OBJECTIVES: Impaired insight into illness is a prevalent feature of schizophrenia, which negatively influences treatment adherence and clinical outcomes. Little is known about the effects of aging on insight impairment. We aimed to review the available research literature on the effects of aging on insight into illness in schizophrenia, in relation to positive, negative, and cognitive symptoms. Ultimately, we propose a trajectory of insight in schizophrenia across the lifespan. METHOD: A systematic Medline® literature search was conducted, searching for English language studies describing the relationship of insight into illness in schizophrenia with aging. RESULTS: We identified 62 studies. Insight impairment is associated with illness severity, premorbid intellectual function (i.e. IQ), executive function, and memory. Insight impairment improves modestly during midlife, worsening again in late life. It tends to fluctuate with each episode of psychosis, likely in relation to worsening positive symptoms that improve with antipsychotic treatment. The relationship between insight impairment and cognitive dysfunction appears to attenuate with age, while the relationship with lower premorbid intellectual function is preserved. The association between impaired insight and negative symptoms is unclear. CONCLUSIONS: The available literature suggests that the course of insight impairment follows a U-shaped curve, where insight impairment is severe during the first episode of psychosis, modestly improves over midlife, and declines again in late life. Future studies are required to investigate the trajectory of insight into illness and its core domains across the lifespan from prodromal phase to late life.
OBJECTIVES: Impaired insight into illness is a prevalent feature of schizophrenia, which negatively influences treatment adherence and clinical outcomes. Little is known about the effects of aging on insight impairment. We aimed to review the available research literature on the effects of aging on insight into illness in schizophrenia, in relation to positive, negative, and cognitive symptoms. Ultimately, we propose a trajectory of insight in schizophrenia across the lifespan. METHOD: A systematic Medline® literature search was conducted, searching for English language studies describing the relationship of insight into illness in schizophrenia with aging. RESULTS: We identified 62 studies. Insight impairment is associated with illness severity, premorbid intellectual function (i.e. IQ), executive function, and memory. Insight impairment improves modestly during midlife, worsening again in late life. It tends to fluctuate with each episode of psychosis, likely in relation to worsening positive symptoms that improve with antipsychotic treatment. The relationship between insight impairment and cognitive dysfunction appears to attenuate with age, while the relationship with lower premorbid intellectual function is preserved. The association between impaired insight and negative symptoms is unclear. CONCLUSIONS: The available literature suggests that the course of insight impairment follows a U-shaped curve, where insight impairment is severe during the first episode of psychosis, modestly improves over midlife, and declines again in late life. Future studies are required to investigate the trajectory of insight into illness and its core domains across the lifespan from prodromal phase to late life.
Authors: Yu-Tao Xiang; Ying Wang; Chuan-Yue Wang; Helen F K Chiu; Qi Chen; Sandra S M Chan; Kelly Y C Lai; Edwin H M Lee; Gabor S Ungvari Journal: Compr Psychiatry Date: 2011-05-31 Impact factor: 3.735
Authors: R Schennach; S Meyer; F Seemüller; M Jäger; M Schmauss; G Laux; H Pfeiffer; D Naber; L G Schmidt; W Gaebel; J Klosterkötter; I Heuser; W Maier; M R Lemke; E Rüther; S Klingberg; M Gastpar; H-J Möller; M Riedel Journal: Eur Psychiatry Date: 2012-04-28 Impact factor: 5.361
Authors: Philip Gerretsen; David D Pothier; Carolyn Falls; Maxine Armstrong; Thushanthi Balakumar; Hiroyuki Uchida; David C Mamo; Bruce G Pollock; Ariel Graff-Guerrero Journal: Psychiatry Res Date: 2017-02-13 Impact factor: 3.222
Authors: Paul H Lysaker; Michelle L Pattison; Bethany L Leonhardt; Scott Phelps; Jenifer L Vohs Journal: World Psychiatry Date: 2018-02 Impact factor: 49.548
Authors: Julia Kim; Yasaman Kambari; Anmol Taggar; Lena C Quilty; Peter Selby; Fernando Caravaggio; Fumihiko Ueno; Jianmeng Song; Bruce G Pollock; Ariel Graff-Guerrero; Philip Gerretsen Journal: Nicotine Tob Res Date: 2022-03-01 Impact factor: 4.244
Authors: Philip Gerretsen; Julia Kim; Parita Shah; Lena Quilty; Thushanthi Balakumar; Fernando Caravaggio; Eric Plitman; Jun Ku Chung; Yusuke Iwata; Bruce G Pollock; Satya Dash; Sanjeev Sockalingam; Ariel Graff-Guerrero Journal: J Clin Hypertens (Greenwich) Date: 2018-03-10 Impact factor: 3.738
Authors: Sarah V Clark; Vijay A Mittal; Jessica A Bernard; Aral Ahmadi; Tricia Z King; Jessica A Turner Journal: Schizophr Res Date: 2017-07-05 Impact factor: 4.939
Authors: Julia Kim; Aron Amaev; Lena C Quilty; Peter Selby; Parita Shah; Fernando Caravaggio; Fumihiko Ueno; Bruce G Pollock; Ariel Graff-Guerrero; Philip Gerretsen Journal: J Gambl Stud Date: 2021-06-24
Authors: Philip Gerretsen; Julia Kim; Parita Shah; Lena Quilty; Thushanthi Balakumar; Fernando Caravaggio; Eric Plitman; Jun Ku Chung; Yusuke Iwata; Bruce G Pollock; Satya Dash; Sanjeev Sockalingam; Ariel Graff-Guerrero Journal: Obes Med Date: 2018-02-12